NASDAQ:LHCG - LHC Group Stock Price, Price Target & More

Get Started

$74.65 +1.31 (+1.79 %)

(As of 05/23/2018 11:06 AM ET)

Previous Close$73.34

Today's Range$73.21 - $74.71

52-Week Range$56.76 - $76.91

Volume38,265 shs

Average Volume320,776 shs

Market Capitalization$1.36 billion

P/E Ratio30.85

Dividend YieldN/A

Beta0.67

About LHC Group (NASDAQ:LHCG)

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The Community-Based Services segment offers a range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. The Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments. The company also operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. As of December 31, 2017, it operated 318 home health services locations, 91 hospice locations, 12 community-based service locations, and 11 long-term acute care hospitals with 15 locations. LHC Group, Inc. was founded in 1994 and is based in Lafayette, Louisiana.

Receive LHCG News and Ratings via Email

Sign-up to receive the latest news and ratings for LHCG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Home health care services

Sub-IndustryHealth Care Services

SectorMedical

SymbolNASDAQ:LHCG

CUSIP50187A10

Webwww.lhcgroup.com

Phone337-233-1307

Debt

Debt-to-Equity Ratio0.24

Current Ratio1.65

Quick Ratio1.65

Price-To-Earnings

Trailing P/E Ratio30.85

Forward P/E Ratio21.33

P/E Growth1.18

Sales & Book Value

Annual Sales$1.07 billion

Price / Sales1.27

Cash Flow$3.2135 per share

Price / Cash23.23

Book Value$28.15 per share

Price / Book2.65

Profitability

EPS (Most Recent Fiscal Year)$2.42

Net Income$50.11 million

Net Margins4.07%

Return on Equity9.29%

Return on Assets5.97%

Miscellaneous

Employees14,554

Outstanding Shares18,280,000

LHC Group (NASDAQ:LHCG) Frequently Asked Questions

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings results on Wednesday, May, 2nd. The health services provider reported $0.63 EPS for the quarter, topping the Zacks' consensus estimate of $0.60 by $0.03. The health services provider earned $291.10 million during the quarter, compared to analysts' expectations of $295.21 million. LHC Group had a return on equity of 9.29% and a net margin of 4.07%. The firm's revenue was up 19.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.53 EPS. View LHC Group's Earnings History.

When is LHC Group's next earnings date?

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for LHC Group.

What guidance has LHC Group issued on next quarter's earnings?

LHC Group updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $3.45-$3.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.50. The company issued revenue guidance of $1.81-$1.86, compared to the consensus revenue estimate of $1.86 billion.

What price target have analysts set for LHCG?

10 Wall Street analysts have issued twelve-month price objectives for LHC Group's stock. Their forecasts range from $71.00 to $85.00. On average, they anticipate LHC Group's stock price to reach $77.5556 in the next year. View Analyst Ratings for LHC Group.

Are investors shorting LHC Group?

LHC Group saw a decrease in short interest in the month of April. As of April 13th, there was short interest totalling 1,100,173 shares, a decrease of 25.7% from the March 30th total of 1,481,286 shares. Based on an average daily volume of 430,833 shares, the days-to-cover ratio is currently 2.6 days. Approximately 6.9% of the company's stock are short sold.

Who are some of LHC Group's key competitors?

Some companies that are related to LHC Group include Chemed (CHE), Amedisys Home Health and Hospice Care (AMED), Addus Homecare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL).

Who are LHC Group's key executives?

LHC Group's management team includes the folowing people:

Mr. Keith G. Myers, Co-Founder, Chairman & CEO (Age 59)
Mr. Donald D. Stelly, Pres & COO (Age 49)
Mr. Joshua L. Proffitt, Exec. VP of Corp. Devel., CFO & Treasurer (Age 40)
Mr. John L. Indest, Consultant & Director (Age 66)
Mr. John M. Thompson Jr., Sr. VP & Chief Information Officer

Has LHC Group been receiving favorable news coverage?

News articles about LHCG stock have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. LHC Group earned a news sentiment score of 0.19 on Accern's scale. They also gave headlines about the health services provider an impact score of 46.61 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are LHC Group's major shareholders?

LHC Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.28%), Dimensional Fund Advisors LP (6.68%), Royal Bank of Canada (3.37%), Millennium Management LLC (3.18%), Rothschild Asset Management Inc. (2.99%) and Northern Trust Corp (2.06%). Company insiders that own LHC Group stock include Coliseum Capital Management, L, Donald Dwayne Stelly, Jeff Reibel, Joshua L Proffitt, Keith G Myers and Kenneth E Thorpe. View Institutional Ownership Trends for LHC Group.

Which major investors are selling LHC Group stock?

LHCG stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Robeco Institutional Asset Management B.V., State of Tennessee Treasury Department, Sivik Global Healthcare LLC, Rothschild Asset Management Inc., Quantbot Technologies LP, Comerica Bank and Smith Asset Management Group LP. Company insiders that have sold LHC Group company stock in the last year include Coliseum Capital Management, L, Donald Dwayne Stelly, Jeff Reibel and Joshua L Proffitt. View Insider Buying and Selling for LHC Group.

Which major investors are buying LHC Group stock?

LHCG stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Coliseum Capital Management LLC, Royal Bank of Canada, BlackRock Inc., Wells Fargo & Company MN, Dalton Greiner Hartman Maher & Co., Tygh Capital Management Inc. and JPMorgan Chase & Co.. View Insider Buying and Selling for LHC Group.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $73.83.

How big of a company is LHC Group?

LHC Group has a market capitalization of $1.36 billion and generates $1.07 billion in revenue each year. The health services provider earns $50.11 million in net income (profit) each year or $2.42 on an earnings per share basis. LHC Group employs 14,554 workers across the globe.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]

MarketBeat Community Rating for LHC Group (LHCG)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		213 (Vote Outperform)
Underperform Votes:		238 (Vote Underperform)
Total Votes:		451

MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote "Outperform" if you believe LHCG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LHCG will underperform the S&P 500 over the long term. You may vote once every thirty days.

LHC Group (NASDAQ:LHCG) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

10 Wall Street analysts have issued ratings and price targets for LHC Group in the last 12 months. Their average twelve-month price target is $77.5556, suggesting that the stock has a possible upside of 3.89%. The high price target for LHCG is $85.00 and the low price target for LHCG is $71.00. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.90	2.90	2.90	2.90
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$77.5556	$77.5556	$76.8889	$76.6667
Price Target Upside:	3.89% upside	14.05% upside	20.33% upside	15.25% upside

LHC Group (NASDAQ:LHCG) Consensus Price Target History

Price Target History for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ:LHCG) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/6/2018	William Blair	Reiterated Rating	Buy		Medium
4/4/2018	Craig Hallum	Boost Price Target	Buy	$70.00 ➝ $80.00	High
4/4/2018	Jefferies Group	Reiterated Rating	Buy ➝ Buy	$84.00	High
3/2/2018	Stephens	Set Price Target	Buy	$74.00	Low
12/7/2017	Oppenheimer	Reiterated Rating	Buy	$85.00	Low
11/28/2017	Robert W. Baird	Set Price Target	Hold	$71.00	Low
11/7/2017	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$70.00 ➝ $81.00	N/A
11/3/2017	SunTrust Banks	Reiterated Rating	Buy	$75.00	N/A
8/21/2017	Bank of America	Initiated Coverage	Buy ➝ Buy	$76.00	Low
6/8/2017	Benchmark	Boost Price Target	Buy ➝ Buy	$63.00 ➝ $72.00	Medium

(Data available from 5/23/2016 forward)

LHC Group (NASDAQ:LHCG) Earnings History and Estimates Chart

Earnings by Quarter for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ:LHCG) Earnings Estimates

2018 EPS Consensus Estimate: $3.45
2019 EPS Consensus Estimate: $4.15

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$0.53	$0.61	$0.58
Q2 2018	4	$0.76	$0.90	$0.84
Q3 2018	4	$0.91	$0.97	$0.94
Q4 2018	4	$1.00	$1.16	$1.09
Q1 2019	3	$0.82	$0.95	$0.88
Q2 2019	3	$1.00	$1.06	$1.03
Q3 2019	3	$1.06	$1.08	$1.07
Q4 2019	3	$1.15	$1.21	$1.18

LHC Group (NASDAQ LHCG) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/1/2018
5/2/2018	Q1 2018	$0.60	$0.63	$295.21 million	$291.10 million	View	N/A
2/28/2018	Q4 2017	$0.62	$0.62	$280.82 million	$292.40 million	View	Listen
11/6/2017	Q3 2017	$0.60	$0.64	$265.35 million	$272.90 million	View	N/A
8/2/2017	Q2 2017	$0.54	$0.6290	$254.10 million	$260.20 million	View	Listen
5/3/2017	Q1 2017	$0.44	$0.48	$241.64 million	$246.62 million	View	N/A
3/8/2017	Q4 2016	$0.57	$0.58	$233.82 million	$235.44 million	View	Listen
11/2/2016	Q316	$0.50	$0.54	$224.60 million	$230.00 million	View	N/A
8/3/2016	Q2	$0.52	$0.52	$221.09 million	$226.00 million	View	N/A
5/4/2016	Q116	$0.37	$0.44	$214.41 million	$222.60 million	View	Listen
3/2/2016	Q415	$0.46	$0.53	$213.35 million	$219.00 million	View	N/A
11/4/2015	Q315	$0.43	$0.50	$199.40 million	$204.10 million	View	Listen
8/5/2015	Q215	$0.41	$0.51	$193.75 million	$200.20 million	View	Listen
5/6/2015	Q115	$0.35	$0.39	$188.90 million	$193.10 million	View	N/A
2/25/2015	Q414	$0.33	$0.45	$190.25 million	$193.40 million	View	Listen
11/5/2014	Q314	$0.34	$0.36	$185.00 million	$187.70 million	View	N/A
8/6/2014	Q214	$0.32	$0.35	$179.90 million	$188.90 million	View	Listen
5/7/2014	Q114	$0.27	$0.24	$166.15 million	$163.70 million	View	Listen
3/5/2014	Q413	$0.32	$0.29	$168.74 million	$165.30 million	View	Listen
11/6/2013	Q313	$0.31	$0.31	$167.61 million	$164.70 million	View	N/A
8/7/2013	Q2 2013	$0.28	$0.34	$166.50 million	$166.30 million	View	N/A
5/8/2013	Q1 2013	$0.33	$0.37	$164.68 million	$162.00 million	View	N/A
3/6/2013	Q4 2012	$0.37	$0.43	$160.93 million	$161.80 million	View	N/A
11/7/2012	Q312	$0.37	$0.36	$159.89 million	$158.90 million	View	N/A
8/6/2012		$0.39	$0.35			View	N/A
5/2/2012		$0.36	$0.44			View	N/A
2/29/2012		$0.35	$0.39			View	N/A
11/2/2011		$0.56	($2.08)			View	N/A
8/3/2011		$0.50	$0.56			View	N/A
5/5/2011		$0.36	$0.42			View	N/A
3/2/2011		$0.66	$0.63			View	N/A
11/1/2010	Q3 2010	$0.69	$0.73			View	N/A
8/4/2010	Q2 2010	$0.70	$0.68			View	N/A
4/28/2010	Q1 2010	$0.65	$0.64			View	N/A
3/3/2010	Q4 2009	$0.51	$0.70			View	N/A
10/28/2009	Q3 2009	$0.52	$0.54			View	N/A
8/4/2009	Q2 2009	$0.53	$0.57			View	N/A
5/6/2009	Q1 2009	$0.48	$0.62			View	N/A
3/10/2009	Q4 2008	$0.46	$0.60			View	N/A
10/29/2008	Q3 2008	$0.36	$0.45			View	N/A
7/30/2008	Q2 2008	$0.31	$0.35			View	N/A
4/30/2008	Q1 2008	$0.28	$0.31			View	N/A
2/27/2008	Q4 2007	$0.38	$0.39			View	N/A

(Earnings results data provided by Zacks Investment Research)

LHC Group (NASDAQ:LHCG) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

LHC Group (NASDAQ LHCG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.80%
Institutional Ownership Percentage: 92.50%

Insider Trading History for LHC Group (NASDAQ:LHCG)

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

LHC Group (NASDAQ LHCG) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/17/2018	Joshua L Proffitt	Insider	Sell	10,556	$75.20	$793,811.20
5/10/2018	Jeff Reibel	SVP	Sell	3,000	$72.35	$217,050.00	12,546
3/13/2018	Donald Dwayne Stelly	COO	Sell	14,216	$64.00	$909,824.00
9/8/2017	Donald Dwayne Stelly	COO	Sell	2,650	$65.34	$173,151.00	109,235
6/16/2017	Coliseum Capital Management, L	Director	Sell	14,450	$65.69	$949,220.50
6/9/2017	Coliseum Capital Management, L	Director	Sell	10,215	$65.14	$665,405.10
6/8/2017	Donald Dwayne Stelly	COO	Sell	3,181	$64.97	$206,669.57	114,235
6/7/2017	Coliseum Capital Management, L	Director	Sell	162,524	$62.80	$10,206,507.20
6/6/2017	Coliseum Capital Management, L	Director	Sell	25,000	$63.23	$1,580,750.00
6/5/2017	Coliseum Capital Management, L	Director	Sell	77,524	$61.73	$4,785,556.52
6/2/2017	Coliseum Capital Management, L	Director	Sell	145,850	$61.05	$8,904,142.50
5/30/2017	Coliseum Capital Management, L	Director	Sell	107,463	$60.63	$6,515,481.69
5/19/2017	Coliseum Capital Management, L	Director	Sell	8,632	$60.25	$520,078.00
5/11/2017	Coliseum Capital Management, L	Director	Sell	128,000	$60.99	$7,806,720.00
3/17/2017	Coliseum Capital Management, L	Director	Sell	51,900	$50.26	$2,608,494.00
3/15/2017	Joshua L Proffitt	Insider	Sell	6,984	$51.54	$359,955.36	71,589
3/13/2017	Donald Dwayne Stelly	COO	Sell	13,154	$51.81	$681,508.74	128,089
12/16/2016	Keith G Myers	CEO	Sell	31,139	$43.91	$1,367,313.49	144,615
12/13/2016	Keith G Myers	CEO	Sell	33,261	$43.58	$1,449,514.38	144,615
12/12/2016	Coliseum Capital Management, L	Director	Sell	50,100	$43.41	$2,174,841.00
12/1/2016	Coliseum Capital Management, L	Director	Sell	26,000	$42.70	$1,110,200.00
11/29/2016	Coliseum Capital Management, L	Director	Sell	18,228	$43.29	$789,090.12
11/29/2016	Keith G Myers	CEO	Sell	15,652	$43.64	$683,053.28	144,615
11/23/2016	Keith G Myers	CEO	Sell	44,897	$43.54	$1,954,815.38	144,615
11/22/2016	Keith G Myers	CEO	Sell	7,214	$43.53	$314,025.42	144,615
11/21/2016	Keith G Myers	CEO	Sell	18,423	$43.54	$802,137.42	144,615
11/18/2016	Keith G Myers	CEO	Sell	2,203	$43.53	$95,896.59	144,615
11/17/2016	Coliseum Capital Management, L	Director	Sell	45,776	$43.19	$1,977,065.44
11/16/2016	Keith G Myers	CEO	Sell	37,848	$43.69	$1,653,579.12	144,615
11/7/2016	Donald Dwayne Stelly	COO	Sell	2,651	$41.54	$110,122.54	119,216
11/7/2016	Joshua L Proffitt	Insider	Sell	2,098	$41.80	$87,696.40	64,717
8/22/2016	Kenneth E Thorpe	Director	Sell	1,450	$36.88	$53,476.00	17,550
6/10/2016	Joshua L Proffitt	EVP	Sell	5,444	$42.65	$232,186.60	47,817
6/9/2016	Coliseum Capital Management, L	Director	Sell	140,000	$43.64	$6,109,600.00
6/8/2016	Donald Dwayne Stelly	COO	Sell	1,326	$43.55	$57,747.30	124,216
5/27/2016	Keith G Myers	CEO	Sell	49,000	$41.09	$2,013,410.00	170,938
5/25/2016	Keith G Myers	CEO	Sell	126,000	$41.96	$5,286,960.00	300,881
5/24/2016	Keith G Myers	CEO	Sell	75,000	$42.19	$3,164,250.00	300,881
5/23/2016	Keith G Myers	CEO	Sell	21,000	$41.16	$864,360.00	300,881
3/14/2016	Donald Dwayne Stelly	COO	Sell	12,952	$35.51	$459,925.52	96,764
2/3/2016	Keith G Myers	CEO	Sell	55,000	$36.60	$2,013,000.00	282,326
1/5/2016	Keith G Myers	CEO	Sell	55,000	$43.13	$2,372,150.00	282,326
1/4/2016	Keith G Myers	CEO	Sell	24,300	$43.47	$1,056,321.00	282,326
12/11/2015	Coliseum Capital Management, L	Director	Sell	54,000	$45.90	$2,478,600.00
12/2/2015	Coliseum Capital Management, L	Director	Sell	24,549	$46.13	$1,132,445.37
12/2/2015	Keith G Myers	CEO	Sell	55,000	$46.20	$2,541,000.00	282,326
12/1/2015	Coliseum Capital Management, L	Director	Sell	124,905	$46.09	$5,756,871.45
11/30/2015	Coliseum Capital Management, L	Director	Sell	18,580	$47.09	$874,932.20
11/27/2015	Ronald T Nixon	Director	Sell	1,695	$48.06	$81,461.70	35,200
11/18/2015	Donald Dwayne Stelly	COO	Sell	1,353	$45.36	$61,372.08	87,615
11/17/2015	Coliseum Capital Management, L	Director	Sell	56,017	$45.48	$2,547,653.16
11/12/2015	Coliseum Capital Management, L	Director	Sell	78,000	$47.24	$3,684,720.00
11/9/2015	Donald Dwayne Stelly	COO	Sell	4,732	$47.35	$224,060.20	89,615
11/2/2015	Keith G Myers	CEO	Sell	55,000	$45.67	$2,511,850.00	283,391
10/5/2015	Keith G Myers	CEO	Sell	55,000	$43.28	$2,380,400.00	283,391
9/11/2015	Coliseum Capital Management, L	Director	Sell	285,846	$46.67	$13,340,432.82
9/8/2015	Coliseum Capital Management, L	Director	Sell	147,671	$46.96	$6,934,630.16
9/1/2015	Keith G Myers	CEO	Sell	55,000	$43.54	$2,394,700.00	283,391
8/19/2015	Coliseum Capital Management, L	Director	Sell	13,818	$47.68	$658,842.24
8/17/2015	Coliseum Capital Management, L	Director	Sell	77,390	$47.56	$3,680,668.40
7/7/2015	Keith G Myers	CEO	Sell	21,651	$37.47	$811,262.97
7/2/2015	Keith G Myers	CEO	Sell	33,349	$37.31	$1,244,251.19
6/12/2015	Coliseum Capital Management, L	Director	Sell	169,987	$36.51	$6,206,225.37
6/9/2015	Coliseum Capital Management, L	Director	Sell	15,606	$36.36	$567,434.16
6/9/2015	Donald Dwayne Stelly	COO	Sell	1,724	$36.20	$62,408.80
6/5/2015	Coliseum Capital Management, L	Director	Sell	88,494	$36.29	$3,211,447.26
6/4/2015	Ronald T Nixon	Director	Sell	4,000	$36.25	$145,000.00
6/3/2015	Keith G Myers	CEO	Sell	16,800	$36.04	$605,472.00
6/2/2015	Keith G Myers	CEO	Sell	38,200	$36.96	$1,411,872.00
5/6/2015	Keith G Myers	CEO	Sell	17,505	$30.09	$526,725.45
5/5/2015	Keith G Myers	CEO	Sell	37,495	$31.22	$1,170,593.90
3/12/2015	Donald Dwayne Stelly	COO	Sell	11,753	$32.27	$379,269.31
3/12/2015	Joshua L Proffitt	EVP	Sell	3,317	$32.37	$107,371.29
9/8/2014	Donald Dwayne Stelly	COO	Sell	4,732	$24.98	$118,205.36
8/27/2014	Keith G Myers	CEO	Sell	48,018	$25.66	$1,232,141.88
8/22/2014	Keith G Myers	CEO	Sell	24,234	$25.24	$611,666.16
8/21/2014	John L Indest	Director	Sell	4,200	$25.22	$105,924.00
8/21/2014	Keith G Myers	CEO	Sell	44,631	$25.23	$1,126,040.13
8/20/2014	Coliseum Capital Management, L	Director	Sell	62,000	$25.32	$1,569,840.00
8/20/2014	Keith G Myers	CEO	Sell	77,351	$25.33	$1,959,300.83
8/18/2014	Coliseum Capital Management, L	Director	Sell	158,011	$25.60	$4,045,081.60
8/18/2014	Donald Dwayne Stelly	COO	Sell	1,725	$25.62	$44,194.50
8/18/2014	Joshua L Proffitt	EVP	Sell	1,294	$25.58	$33,100.52
5/13/2014	Donald Dwayne Stelly	COO	Sell	10,472	$21.08	$220,749.76	97,775
5/12/2014	Joshua Proffitt	EVP	Sell	1,908	$21.13	$40,316.04	27,715
3/14/2014	Ted Hoyt	Director	Sell	5,000	$21.85	$109,250.00	34,550
3/10/2014	Ted Hoyt	Director	Sell	5,000	$22.35	$111,750.00	34,550
9/10/2013	Donald Dwayne Stelly	COO	Sell	1,354	$23.05	$31,209.70
8/13/2013	Donald Dwayne Stelly	COO	Sell	1,723	$26.08	$44,935.84	62,885
8/12/2013	Ted Hoyt	Director	Sell	1,000	$26.36	$26,360.00	36,950
6/13/2013	Keith G Myers	CEO	Sell	9,662	$22.91	$221,356.42
6/12/2013	Keith G Myers	CEO	Sell	61,500	$22.44	$1,380,060.00
6/11/2013	Coliseum Capital Management, L	Director	Buy	14,000	$22.20	$310,800.00
6/7/2013	Keith G Myers	CEO	Sell	11,547	$22.08	$254,957.76
6/4/2013	Keith G Myers	CEO	Sell	33,000	$22.45	$740,850.00
5/30/2013	Keith G Myers	CEO	Sell	32,738	$22.51	$736,932.38
5/24/2013	Keith G Myers	CEO	Sell	26,553	$22.54	$598,504.62
5/13/2013	John L Indest	Director	Sell	5,900	$22.76	$134,284.00
3/15/2013	Coliseum Capital Management, L	Director	Buy	27,201	$21.18	$576,117.18
3/12/2013	Coliseum Capital Management, L	Director	Buy	128,400	$19.89	$2,553,876.00
12/14/2012	Coliseum Capital Management, L	Director	Buy	44,100	$20.49	$903,609.00
12/4/2012	Donald Dwayne Stelly	COO	Sell	4,117	$19.52	$80,363.84
11/29/2012	Coliseum Capital Management, L	Director	Buy	101,200	$18.75	$1,897,500.00
9/5/2012	Coliseum Capital Management, L	Major Shareholder	Buy	34,947	$17.45	$609,825.15
8/8/2012	Coliseum Capital Management, L	Major Shareholder	Buy	84,546	$16.54	$1,398,390.84

(Data available from 1/1/2013 forward)

LHC Group (NASDAQ LHCG) News Headlines

Source:

Date	Headline
	LHC Group’s First-Quarter CMS Star Ratings Continue to Outperform National Averages finance.yahoo.com - May 23 at 8:36 AM
	LHC Group, Inc. (LHCG) Expected to Announce Quarterly Sales of $509.08 Million www.americanbankingnews.com - May 23 at 1:46 AM
	U.S. Department of Health and Human Services Chief Technology Officer Bruce D. Greenstein to Join LHC Group Management Team as Chief Innovation & Technology Officer finance.yahoo.com - May 22 at 8:38 AM
	LHC Group, Inc. (LHCG) Expected to Post Earnings of $0.81 Per Share www.americanbankingnews.com - May 21 at 11:10 PM
	Critical Survey: LHC Group (LHCG) and Civitas Solutions (CIVI) www.americanbankingnews.com - May 21 at 1:07 PM
	LHC Group (LHCG) versus Civitas Solutions (CIVI) Critical Contrast www.americanbankingnews.com - May 21 at 3:08 AM
	LHC Group (LHCG) & BioScrip (BIOS) Head to Head Survey www.americanbankingnews.com - May 20 at 3:21 PM
	LHC Group (LHCG) Rating Increased to Buy at BidaskClub www.americanbankingnews.com - May 18 at 3:09 PM
	Does LHC Group Inc’s (NASDAQ:LHCG) PE Ratio Signal A Selling Opportunity? finance.yahoo.com - May 18 at 9:12 AM
	LHC Group, Inc. (LHCG) Insider Sells $793,811.20 in Stock www.americanbankingnews.com - May 17 at 7:55 PM
	Head-To-Head Contrast: Civitas Solutions (CIVI) versus LHC Group (LHCG) www.americanbankingnews.com - May 17 at 3:25 PM
	LHC Group (LHCG) vs. Addus HomeCare (ADUS) Financial Comparison www.americanbankingnews.com - May 15 at 11:27 AM
	Jeff Reibel Sells 3,000 Shares of LHC Group, Inc. (LHCG) Stock www.americanbankingnews.com - May 11 at 8:53 PM
	LHC Group to Present at Bank of America Merrill Lynch 2018 Health Care Conference finance.yahoo.com - May 10 at 5:28 PM
	LHC Group (LHCG) Given Buy Rating at William Blair www.americanbankingnews.com - May 7 at 2:57 PM
	LHC Group, Inc. Forecasted to Earn FY2018 Earnings of $3.52 Per Share (LHCG) www.americanbankingnews.com - May 7 at 3:46 AM
	Q3 2018 EPS Estimates for LHC Group, Inc. Raised by William Blair (LHCG) www.americanbankingnews.com - May 7 at 3:08 AM
	Q2 2018 Earnings Estimate for LHC Group, Inc. Issued By Jefferies Group (LHCG) www.americanbankingnews.com - May 7 at 1:58 AM
	LHC Group, Inc. (LHCG) Given Average Rating of "Buy" by Brokerages www.americanbankingnews.com - May 6 at 7:39 PM
	LHC Group's (LHCG) CEO Keith Myers on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 6 at 7:10 PM
	$509.51 Million in Sales Expected for LHC Group, Inc. (LHCG) This Quarter www.americanbankingnews.com - May 6 at 2:56 AM
	Zacks: Brokerages Expect LHC Group, Inc. (LHCG) to Post $0.84 Earnings Per Share www.americanbankingnews.com - May 4 at 4:00 PM
	Blog Exposure - Amedisys Acquires East Tennessee Personal Care Service to Expand Personal Care to Tennessee finance.yahoo.com - May 4 at 8:39 AM
	Edited Transcript of LHCG earnings conference call or presentation 3-May-18 3:00pm GMT finance.yahoo.com - May 4 at 8:39 AM
	LHC Group, Inc. to Post FY2018 Earnings of $3.54 Per Share, SunTrust Banks Forecasts (LHCG) www.americanbankingnews.com - May 4 at 8:16 AM
	LHC: 1Q Earnings Snapshot finance.yahoo.com - May 3 at 8:36 AM
	LHC Group (LHCG) Posts Earnings Results, Beats Estimates By $0.03 EPS www.americanbankingnews.com - May 2 at 7:32 PM
	LHC Group (LHCG) Issues FY18 Earnings Guidance www.americanbankingnews.com - May 2 at 5:46 PM
	BRIEF-LHC Group Q1 Earnings Per Share $0.28 www.reuters.com - May 2 at 5:14 PM
	LHC Group Announces First Quarter 2018 Financial Results finance.yahoo.com - May 2 at 5:14 PM
	LHC Group (LHCG) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - May 2 at 1:09 PM
	Head to Head Survey: LHC Group (LHCG) and Civitas Solutions (CIVI) www.americanbankingnews.com - April 29 at 9:21 AM
	LHC Group, Inc. (LHCG) Short Interest Update www.americanbankingnews.com - April 29 at 2:44 AM
	LHC Group (LHCG) Upgraded to Strong-Buy at BidaskClub www.americanbankingnews.com - April 26 at 1:10 PM
	Stock scores you need to consult before buying or selling: Caterpillar, E*TRADE Financial, Intel, LHC Group, XPO Logistics www.bizjournals.com - April 25 at 5:13 PM
	LHC Group (LHCG) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - April 25 at 5:46 AM
	LHC Group (LHCG): Moving Average Crossover Alert finance.yahoo.com - April 23 at 4:58 PM
	Head to Head Contrast: LHC Group (LHCG) & BioScrip (BIOS) www.americanbankingnews.com - April 22 at 7:24 PM
	LHC Group Announces First Quarter 2018 Earnings Release and Conference Call Dates finance.yahoo.com - April 19 at 5:17 PM
	SunTrust Banks Comments on LHC Group, Inc.'s Q2 2018 Earnings (LHCG) www.americanbankingnews.com - April 19 at 6:26 AM
	$294.55 Million in Sales Expected for LHC Group, Inc. (LHCG) This Quarter www.americanbankingnews.com - April 19 at 3:06 AM
	BidaskClub Downgrades LHC Group (LHCG) to Buy www.americanbankingnews.com - April 18 at 5:48 PM
	$0.60 Earnings Per Share Expected for LHC Group, Inc. (LHCG) This Quarter www.americanbankingnews.com - April 17 at 1:17 PM
	LHC Group (LHCG) Cut to "Hold" at BidaskClub www.americanbankingnews.com - April 16 at 9:16 AM
	Signature Healthcare prepping to expand this line of business in 2019 finance.yahoo.com - April 12 at 9:18 AM
	LHC Group, Inc. (LHCG) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - April 11 at 5:43 PM
	Active-Investors: Free Post Earnings Research Report: LHC Group's Quarterly Revenue Surged 24.2%; Adjusted EPS Gained 7% www.finanznachrichten.de - April 10 at 8:58 AM
	Free Post Earnings Research Report: LHC Group’s Quarterly Revenue Surged 24.2%; Adjusted EPS Gained 7% finance.yahoo.com - April 10 at 8:58 AM
	LHC Group (LHCG) Upgraded to Buy at BidaskClub www.americanbankingnews.com - April 10 at 8:27 AM
	LHC Group (LHCG) Downgraded by Zacks Investment Research to "Hold" www.americanbankingnews.com - April 7 at 11:01 PM

LHC Group (NASDAQ:LHCG) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

LHC Group (NASDAQ:LHCG) Income Statement, Balance Sheet and Cash Flow Statement

LHC Group (NASDAQ LHCG) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff